Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 64 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Icosapent ethyl for reducing the risk of cardiovascular events	Icosapent ethyl (Miraxion; LAX-101d; AMR-101; Vascepa)	Cardiovascular events	Cardiovascular System	2020	View \| Download
Human acellular vessel for vascular access for haemodialysis in end-stage renal disease	Human Acellular Vessel (HumaGraft; Humacyl)	Arterial venous access	Cardiovascular System	2019	View \| Download
Granexin Gel for Diabetic Foot Ulcers	Granexin (ACT-1)	Diabetic foot ulcer (DFU)	Cardiovascular System , Dermatology , Endocrine Nutritional and Metabolic Disorders	2018	View \| Download
Evolocumab for preventing major cardiovascular events in adults with a high risk of cardiovascular events	Evolocumab	Cardiovascular events	Cardiovascular System	2023	View \| Download
Eplontersen for treating transthyretin amyloid cardiomyopathy	Eplontersen (ION-682884;AKCEA TTR-LRx)	Transthyretin amyloid cardiomyopathy	Cardiovascular System	2024	View \| Download
Entresto for chronic heart failure with preserved ejection fraction	Entresto; LCZ 696 (fixed dose combination: Sacubitril; Valsartan)	Heart failure (HF)	Cardiovascular System	2019	View \| Download
Empagliflozin for treatment of chronic heart failure with reduced ejection fraction	Empagliflozin (Jardiance; DINAMO)	Heart failure (HF)	Cardiovascular System	2020	View \| Download
Empagliflozin for treating chronic kidney disease	Empagliflozin (Jardiance; DINAMO)	Chronic kidney disease (CKD)	Cardiovascular System , Nephrology	2022	View \| Download
Empagliflozin for the treatment of acute myocardial infarction to reduce heart failure and mortality	Empagliflozin (Jardiance; DINAMO)	Heart failure (HF)	Cardiovascular System	2022	View \| Download
Empagliflozin for Chronic Heart Failure with Preserved Ejection Fraction	Empagliflozin (Jardiance; DINAMO)	Heart failure (HF)	Cardiovascular System	2021	View \| Download